Voronoi Inc
KOSDAQ:310210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Voronoi Inc
KOSDAQ:310210
|
KR |
|
T
|
Task Group Holdings Ltd
ASX:TSK
|
NZ |
|
C
|
Coca-Cola Consolidated Inc
F:CC5
|
US |
|
J
|
JCDecaux SE
F:DCS
|
FR |
|
Teleperformance SE
OTC:TLPFF
|
FR |
|
Alpine 4 Holdings Inc
OTC:ALPP
|
US |
|
N
|
Nice D&B Co Ltd
KOSDAQ:130580
|
KR |
|
F
|
Federal Home Loan Mortgage Corp
XHAM:FHL
|
US |
|
Orient Overseas (International) Ltd
F:ORI
|
HK |
Intrinsic Value
Is Voronoi Inc undervalued or overvalued?
See the intrinsic value estimate for Voronoi Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Voronoi Does
Voronoi Inc is a South Korean biopharmaceutical company that discovers and develops small-molecule cancer drugs. It focuses on finding drug candidates that can block the signaling pathways cancer cells use to grow and survive, then advancing those candidates through preclinical and clinical development. The company’s main customers are not patients directly but pharmaceutical partners, healthcare systems, and eventually doctors and hospitals if its drugs win approval.
- Headquarters
- Korea KR
- Employees
- 139
- IPO date
- Jun 24, 2022
Earnings Waterfall
Voronoi Inc
The intrinsic value for Voronoi Inc (310210) under the Base Case is hidden KRW.
Compared with the current market price of 106 100 KRW, the stock appears hidden.